REQUEST A DEMO
Total
USD $0.00
Search more companies

Aburaihan Pharmaceutical Company Public Joint Stock (Iran)

Main Activities: Medicinal and Botanical Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Aburaihan Pharmaceutical Company Public Joint Stock Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Abouraihan Pharmaceutical Co. is a major Iranian company for human drugs and veterinary products. It was established in 1965 with headquarters in Tehran. It deals with the research, development, production and marketing of human and veterinary medicines in various dosage forms, including injections, oral and topical products. Like most of the Iranian pharmaceutical companies, it is ISO certified. Previously, it was known under the name Berlimed and was owned by German Schering Company. In 1981 it changed name and became public.

Headquarters
Tehranpars Cross Road, Khoshvaght Street, No.1
Tehran; Tehran; Postal Code: 1654613111

Contact Details: Purchase the Aburaihan Pharmaceutical Company Public Joint Stock report to view the information.

Website: http://www.aburaihan.com

Basic Information
Total Employees:
Purchase the Aburaihan Pharmaceutical Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Aburaihan Pharmaceutical Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Aburaihan Pharmaceutical Company Public Joint Stock report to view the information.
Incorporation Date:
1965
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
83.694%
Purchase this report to view the information.
35.4%
Purchase this report to view the information.
0.944%
Purchase this report to view the information.
0.626%
Purchase this report to view the information.
0.413%
Company Performance
Financial values in the chart are available after Aburaihan Pharmaceutical Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
7.21%
Total operating revenue
7.56%
Operating profit (EBIT)
-20.18%
EBITDA
-18.98%
Net Profit (Loss) for the Period
-38.42%
Total assets
37.19%
Total equity
-18.73%
Operating Profit Margin (ROS)
-12.39%
Net Profit Margin
-13.13%
Return on Equity (ROE)
-14.49%
Debt to Equity Ratio
93.62%
Quick Ratio
-0.17%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?